Under the liquidity contract entrusted by Innate Pharma to Gilbert Dupont, the following assets appeared on the liquidity account as at June 30, 2013:
- 75,277 shares of Innate Pharma, and
- 184,719.98 euros in cash.
| PR in English | 71.8 KB |
| CP en français | 63.74 KB |